Visual Impairment News and Research

Latest Visual Impairment News and Research

Three-year safety data from INTREPID study of Oraya Therapy™ for wet age-related macular degeneration results announced

Oraya Therapeutics Inc. announced that full results of three-year safety follow-up data from the INTREPID study of Oraya Therapy™ for wet age-related macular degeneration (AMD) further demonstrated a favorable safety profile and also showed that there was no significant difference in vision outcomes in patients treated with Oraya Therapy compared with those receiving anti-vascular endothelial growth factor (anti-VEGF) injections alone.

15 Sep 2014

Lifestyle factors modify vision impairment risk

Smoking, drinking alcohol and physical activity are modifiable behaviours that influence the risk of vision impairment, show findings from the Beaver Dam Eye Study.

28 Aug 2014

Central sclera thickening characterises dome-shaped macula

A dome-shaped macula appears to result from the relative thickening of the central macular sclera, researchers have found.

28 Aug 2014

Simple colour test could detect early onset of nAMD in the UK

A simple colour test that could detect the early onset of a condition which accounts for over half of visual impairment certifications in the UK is being researched by scientists at Aston University.

28 Aug 2014

Study examines ocular changes seen in astronauts to treat spaceflight-induced visual impairment

To reduce and better treat spaceflight-induced visual impairment, University of Houston (UH) optometrists are collaborating on a NASA study that examines ocular changes seen in a number of astronauts.

27 Aug 2014

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

The Perelman School of Medicine at the University of Pennsylvania has launched the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to build on its previous success developing novel therapies for the personalized diagnosis and treatment of retinal and ocular disorders.

22 Aug 2014

French Ministry of Health approves financial support for Second Sight Argus II Retinal Prosthesis System

Second Sight Medical Products Inc. today announces that the French Ministry of Health has officially approved financial support for the Argus II Retinal Prosthesis System. Through the Forfait Innovation scheme, the French Government will pay for the first wave of groundbreaking treatment for 36 patients with severe to total sight loss due to retinitis pigmentosa (RP) in France.

22 Aug 2014

Research: New ways to help visually impaired better navigate everyday life

Visual impairment comes in many forms, and it's on the rise in America. A University of Cincinnati experiment aimed at this diverse and growing population could spark development of advanced tools to help all the aging baby boomers, injured veterans, diabetics and white-cane-wielding pedestrians navigate the blurred edges of everyday life.

12 Aug 2014

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.

11 Aug 2014

Hearing problems reduce active participation of older people in various events

Vision and hearing problems reduce the active participation of older people in various events and activities. This was observed in two studies carried out by the Gerontology Research Center.

6 Aug 2014

Digital reading system opens up new educational opportunities for people with vision impairment

People who are blind can now read more than just words, such as graphs and graphics, following the development of an affordable digital reading system by Curtin University researchers.

30 Jul 2014

Early stage AMD can occur much earlier than previously thought

It is widely accepted that age-related macular degeneration (AMD) is the most common cause of visual impairment and blindness in industrialized countries.

22 Jul 2014

Study shows correlation between education and nearsightedness

Education and behavior have a greater impact on the development of nearsightedness than do genetic factors: With each school year completed, a person becomes more nearsighted.

22 Jul 2014

Phase 3 VIVID-DME trial of EYLEA Injection for treatment of DME shows improvement in visual acuity

Regeneron Pharmaceuticals, Inc. today announced that in the Phase 3 VIVID-DME trial of EYLEA® (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100 (2 years), compared to laser photocoagulation.

18 Jul 2014

LA BioMed researchers launch new project to improve diabetes management

Managing diabetes is a year-round challenge for anyone living with the disease. The challenge is even greater for underserved and uninsured people who often don't have easy access to the care they need to manage their diabetes.

10 Jul 2014

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in moderate-to-severe AD

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema.

10 Jul 2014

Integrated therapies can reduce depression by half among people with low vision due to AMD

The first clinical trial to examine integrated low vision and mental health treatment has shown that the approach can reduce the incidence of depression by half among people with low vision due to age-related macular degeneration (AMD).

9 Jul 2014

Study links nearsightedness to higher education and years spent in school

German researchers have found strong evidence that attaining a higher level of education and spending more years in school are two factors associated with a greater prevalence and severity of nearsightedness, or myopia.

28 Jun 2014

New approaches needed to improve visual accessibility for people with low vision-challenges

New approaches and tools are needed to improve visual accessibility for people with low vision in the "real world," according to a special article in the July issue of , official journal of the the American Academy of Optometry.

25 Jun 2014

Italian Medicines Agency grants marketing authorization to ILUVIEN for chronic DME treatment

pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the Italian Medicines Agency (Agenzia Italiana del Farmaco) has granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.

23 Jun 2014

Visual Impairment News and Research

Latest Visual Impairment News and Research

Three-year safety data from INTREPID study of Oraya Therapy™ for wet age-related macular degeneration results announced

Lifestyle factors modify vision impairment risk

Central sclera thickening characterises dome-shaped macula

Simple colour test could detect early onset of nAMD in the UK

Study examines ocular changes seen in astronauts to treat spaceflight-induced visual impairment

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

French Ministry of Health approves financial support for Second Sight Argus II Retinal Prosthesis System

Research: New ways to help visually impaired better navigate everyday life

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Hearing problems reduce active participation of older people in various events

Digital reading system opens up new educational opportunities for people with vision impairment

Early stage AMD can occur much earlier than previously thought

Study shows correlation between education and nearsightedness

Phase 3 VIVID-DME trial of EYLEA Injection for treatment of DME shows improvement in visual acuity

LA BioMed researchers launch new project to improve diabetes management

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in moderate-to-severe AD

Integrated therapies can reduce depression by half among people with low vision due to AMD

Study links nearsightedness to higher education and years spent in school

New approaches needed to improve visual accessibility for people with low vision-challenges

Italian Medicines Agency grants marketing authorization to ILUVIEN for chronic DME treatment

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Visual Impairment News and Research

Latest Visual Impairment News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in